Hirmand Mohammad

EVP & Chief Medical Officer at Turning Point Therapeutics, Inc.; Interim Chief Medical Officer at MEDIVATION, INC.

Sold, on record
$1.4M
Dollars the filings state
Form 4 sales
5
Latest Feb 9, 2022
Form 144 notices
0
Proposed sales
Companies
2
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale MEDIVATION, INC.Plan not stated
    Nov 9, 2015 2015

    Sold 232 shares at $41.91 ($10k)

    Hirmand Mohammad, Interim Chief Medical Officer

    Sold 0.7% of holdings ($1.4M position)32,188 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale MEDIVATION, INC.Plan not stated
    Dec 3, 2015 +24 days

    Sold 1,075 shares at $43.40 ($47k)

    Hirmand Mohammad, Interim Chief Medical Officer

    Sold 3.3% of holdings ($1.4M position)31,113 shares leftFiling

  3. 3 Form 4 sale MEDIVATION, INC.Plan not stated
    Mar 4, 2016 +92 days

    Sold 1,525 shares at $41.10 ($63k)

    Hirmand Mohammad, Interim Chief Medical Officer

    Sold 3.7% of holdings ($1.7M position)39,342 shares leftFiling

  4. Jan 5, 2021 +1768 days

    Sold 10,300 shares at $120.43 ($1.2M)

    Hirmand Mohammad, EVP and Chief Medical Officer

    Sold 97.3% of holdings ($1.3M position)284 shares leftFirst sale on recordFiling

  5. 5 Form 4 sale Turning Point Therapeutics, Inc.Plan not stated
    Feb 9, 2022 +400 days

    Sold 669 shares at $36.30 ($24k)

    Hirmand Mohammad, EVP & Chief Medical Officer

    Sold 8.9% of holdings ($273k position)6,838 shares leftFiling

Every transaction

Loading transactions…

Sales and notices (5)

Form 144 notices and Form 4 sales by Hirmand Mohammad
Source
Feb 9, 2022Feb 11, 2022Turning Point Therapeutics, Inc.EVP & Chief Medical OfficerForm 4 sale669$24k8.9%Plan not statedSEC
Jan 5, 2021Jan 5, 2021Turning Point Therapeutics, Inc.EVP and Chief Medical OfficerForm 4 sale10,300$1.2M97.3%UnusualSEC
Mar 4, 2016Mar 7, 2016MEDIVATION, INC.Interim Chief Medical OfficerForm 4 sale1,525$63k3.7%Plan not statedSEC
Dec 3, 2015Dec 4, 2015MEDIVATION, INC.Interim Chief Medical OfficerForm 4 sale1,075$47k3.3%Plan not statedSEC
Nov 9, 2015Nov 12, 2015MEDIVATION, INC.Interim Chief Medical OfficerForm 4 sale232$10k0.7%Plan not statedSEC